Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950142-24-003032
Filing Date
2024-12-31
Accepted
2024-12-31 16:04:12
Documents
2
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT eh240570085_3-bonner.html 3  
1 OWNERSHIP DOCUMENT eh240570085_3-bonner.xml 3 5179
2 EXHIBIT 24.1 eh240570085_ex2401.htm EX-24.1 7187
  Complete submission text file 0000950142-24-003032.txt   13837
Mailing Address 100 KING STREET WEST SUITE 3400 TORONTO A6 M5X 1A4
Business Address 100 KING STREET WEST SUITE 3400 TORONTO A6 M5X 1A4 (732) 300-3046
Medicus Pharma Ltd. (Issuer) CIK: 0001997296 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 KING ST W SUITE 3400 TORONTO Z4 M5X 1A4
Business Address
Bonner Carolyn F. (Reporting) CIK: 0002047487 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42408 | Film No.: 241592991